The UFG project is known for its active participation in creating a new digital space and developing biotechnological drugs. The basis of biotechnology development was the extraction of melanin from the strain of black Antarctic yeast Nadsoniella nigra var. Hesuelica.
United Financial Group has presented a small roadmap on its website. It includes the following key points:
- 2019 – company foundation,
- 2020 – release of the first product to the market and development of Alginar,
- 2021 – first dividend payment.
The benefits of investing in the company’s developments are listed on the United Financial Group LLC website:
- broad investment prospects,
- minimum prices for access to all company developments,
- annual dividend payment,
- inheritance of shares in the company,
- participation in important pharmaceutical developments,
- profit from investments in the company’s portfolio.
United Financial Group is represented by several domains and an Instagram account:
- ufgpro.com,
- ufgroup.pro,
- ufgmarket.com,
- www.instagram.com/ufgroup.pro.
The physical address of the project headquarters: United Financial Group LLC, Georgia, Tbilisi, District of Gldani, Omar Khizanishvili str.
Investment opportunities are provided after registration. Investors can invest funds in the development of biotechnological drugs that have shown results in combating cancer. Details of dividends are available after registration.
Possible methods of depositing and withdrawing funds include bank transfer, bank cards, and cryptocurrency wallets. Information on fees and processing speed is not available.
The UFG project offers investors the opportunity to invest in the development of medical drugs without providing confirmed research on effectiveness. Before investing, it is recommended to familiarize yourself with the project details and reviews from other investors.